MEDIOCON INC – Iproxifene is a synthetic selective estrogen receptor modulator (SERM) that has been investigated primarily for its estrogenic and anti-estrogenic properties. It belongs to the benzothiophene-related class of compounds and has been studied in the context of hormone-dependent conditions and bone metabolism.
Iproxifene is a non-steroidal estrogen receptor modulator developed as an investigational compound. It has been studied for its ability to interact with estrogen receptors and produce tissue-dependent estrogenic or anti-estrogenic effects.
The compound has been investigated particularly in relation to postmenopausal bone health and estrogen-dependent conditions, although it is not a widely marketed therapeutic API.
Product Name: Iproxifene
CAS Number: 96847-53-5
Molecular Formula: C₂₅H₂₈O₃
Molecular Weight: 376.49 g/mol
Chemical Class: Non-Steroidal Estrogen Receptor Modulator
Pharmacological Class: Selective Estrogen Receptor Modulator (SERM)
Synonyms: Iproxifene, ICI 182780-related research compound
Iproxifene interacts with estrogen receptors (ERs) and can produce estrogen-like or anti-estrogenic effects depending on the target tissue and biological context.
Compounds in this class have been investigated for their ability to influence estrogen-responsive pathways involved in:
MEDIOCON INC focuses on supplying pharmaceutical and research-grade active ingredients with emphasis on quality, consistency, technical documentation and reliable supply.
Iproxifene quality evaluation may include:
The exact acceptance criteria should be confirmed against the applicable specification and batch-specific Certificate of Analysis.
Iproxifene may be relevant to:
Iproxifene should be regarded primarily as an investigational/research compound, and its regulatory status should be verified for the intended market.
A reliable authoritative source for the exact current commercial physical appearance specification could not be verified.
Appearance: White to off-white solid/powder
The exact commercial appearance should be confirmed against the applicable MEDIOCON INC product specification and batch COA.
Product availability, packaging configuration, Certificate of Analysis (COA), Safety Data Sheet (SDS/MSDS), technical specifications and analytical documentation should be confirmed with MEDIOCON INC according to customer requirements and applicable regulatory standards.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white solid/powder |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Iproxifene API Manufacturer and Supplier in India (CAS 96847-53-5) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Iproxifene API Manufacturer and Supplier in India is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance